Literature DB >> 2785374

The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection.

V L Ng1, I Gartner, L A Weymouth, C D Goodman, P C Hopewell, W K Hadley.   

Abstract

We describe a system for diagnosis of pulmonary disease in the human immunodeficiency virus-infected patient using induced sputum and other diagnostic procedures. This system has been successfully used at San Francisco (Calif) General Hospital for more than 2 years. It utilizes outpatient facilities and reduces the need for bronchoscopy. Sputum induced by inhalation of 3% saline mist, mucolysed, concentrated by centrifugation, and stained by a rapid modified Giemsa stain was the first diagnostic specimen examined in 404 episodes of suspected human immunodeficiency virus-associated pulmonary disease in 358 patients. Pneumocystis carinii was found in 222 (55%) sputum specimens. In 118 episodes in which the sputum did not contain P carinii, bronchoscopy with transbronchial biopsy and/or bronchoalveolar lavage was performed and P carinii was found in 50 (42%). These 118 bronchoscopy results, as well as evaluation of the subsequent clinical course of those patients who accounted for 64 episodes of lung disease and who did not have bronchoscopy following examination of nondiagnostic induced sputum, indicated a range of sensitivity for detection of P carinii in induced sputum of 74% to 77% and a negative predictive value of 58% to 64%. Mycobacteria were recovered from 11 (6%) of the induced sputum and 6 (12%) of the bronchoscopic specimens containing P carinii. However, only oral or environmental fungi were recovered from P carinii-containing induced sputum or bronchoscopic specimens. For those patients in whom P carinii was not detected, only the bronchoscopic specimens were cultured for Mycobacteria and fungi. Potentially pathogenic Mycobacteria and fungi were recovered from 16 (23.5%) and 34 (50%), respectively, of these P carinii-negative specimens. Analysis of these results, obtained under routine practice conditions, indicates that bronchoscopy should be reserved for those patients whose induced sputum examinations do not show P carinii and that mycobacterial and fungal cultures be performed only on bronchoscopic specimens in which P carinii is not detected.

Entities:  

Mesh:

Year:  1989        PMID: 2785374

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Rapid microscopy technique for detection of Pneumocystis carinii in fresh clinical specimens.

Authors:  G Chichino; A Bruno; C Cevini; S Gatti; M Scaglia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Isolation of opportunistic fungi from bronchoalveolar lavage of compromised hosts in Isfahan, Iran.

Authors:  S Shadzi; M Chadeganipour
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

3.  Comparative recovery of cytomegalovirus from saliva, mucolysed induced sputum, and bronchoalveolar lavage fluid from patients at risk for or with acquired immunodeficiency syndrome.

Authors:  J D Rush; V L Ng; P C Hopewell; W K Hadley; J Mills
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran.

Authors:  Mohammad Mohsen Homayouni; Hamed Behniafar; Amir Sayed Ali Mehbod; Mohammad-Javad Mohammad-Sadeghi; Bahman Maleki
Journal:  J Parasit Dis       Date:  2017-02-28

Review 5.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

6.  Detection of Pneumocystis carinii in respiratory specimens by PCR-solution hybridization enzyme-linked immunoassay.

Authors:  E Ortona; P Margutti; E Tamburrini; P Mencarini; E Visconti; M Zolfo; A Siracusano
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain.

Authors:  V L Ng; N A Virani; R E Chaisson; D M Yajko; H T Sphar; K Cabrian; N Rollins; P Charache; M Krieger; W K Hadley
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

8.  Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens.

Authors:  V L Ng; D M Yajko; L W McPhaul; I Gartner; B Byford; C D Goodman; P S Nassos; C A Sanders; E L Howes; G Leoung
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Comparison of shell viral culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects.

Authors:  B Weber; A Hamann; B Ritt; H Rabenau; W Braun; H W Doerr
Journal:  Clin Investig       Date:  1992-06

10.  Detection of Pneumocystis carinii sequences by polymerase chain reaction: animal models and clinical application to noninvasive specimens.

Authors:  K Kitada; S Oka; S Kimura; K Shimada; T Serikawa; J Yamada; H Tsunoo; K Egawa; Y Nakamura
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.